Pharmaco-nutrient interactions - A systematic review of zinc and antihypertensive therapy

International Journal of Clinical Practice

Volumn 67, Issue 8, 2013, Pages 717-725

  Braun, L A ^a,b   Rosenfeldt, F ^c  

^a ALFRED HOSPITAL   (Australia)

^b Australia   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; DOXAZOSIN; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL; PERINDOPRIL; VALSARTAN; VERAPAMIL; ZINC;

DIETARY INTAKE; DRUG EFFICACY; ERYTHROCYTE; HUMAN; HYPERTENSION; NUTRIENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; FOOD-DRUG INTERACTIONS; HUMANS; HYPERTENSION; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TRACE ELEMENTS; ZINC;

EID: 84880702283     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12040     Document Type: Review

References (26)

1. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL,. Zinc and cardiovascular disease. Nutrition 2010; 26: 1050-7.
2. Braun L, Cohen M,. Herbs and Natural Supplements-An Evidence Based Guide, 3rd edn. Sydney: Elsevier; 2010.
3. Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF,. Zinc bioavailability and homeostasis. Am J Clin Nutr 2010; 91: 1478S-83S.
4. Maret W, Sandstead HH,. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006; 20: 3-18.
5. Calhoun DA, Jones D, Textor S, et al., Resistant hypertension: diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-26.
6. Liamis G, Milionis H, Elisaf M,. Blood pressure drug therapy and electrolyte disturbances. Int J Clin Pract 2008; 62: 1572-80.
7. Jansen J, Karges W, Rink L,. Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem 2009; 20: 399-417.
8. Wester PO,. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand 1980; 208: 209-12.
9. Golik A, Modai D, Weissgarten J, et al., Hydrochlorothiazide-amiloride causes excessive urinary zinc excretion. Clin Pharmacol Ther 1987; 42: 42-4.
10. Khedun SM, Naicker T, Maharaj B,. Zinc, hydrochlorothiazide and sexual dysfunction. Cent Afr J Med 1995; 41: 312-5.
11. Baykal Y, Yilmaz MI, Celik T, et al., Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 2003; 21: 1207-11.
12. Rubio-Luengo MA, Maldonado-Martin A, Gil-Extremera B, Gonzalez-Gomez L, Luna del Castillo JD,. Variations in magnesium and zinc in hypertensive patients receiving different treatments. Am J Hypertens 1995; 8: 689-95.
13. Abu-Hamdan DK, Desai H, Sondheimer J, Felicetta J, Mahajan S, McDonald F,. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988; 3: 303S-8S.
14. Golik A, Modai D, Averbukh Z, et al., Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990; 39: 665-7.
15. Golik A, Zaidenstein R, Dishi V, et al., Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998; 17: 75-8.
16. Golik A, Averbukh Z, Cohn M, et al., Effect of diuretics on captopril-induced urinary zinc excretion. Eur J Clin Pharmacol 1990; 38: 359-61.
17. Tubek S,. Urinary zinc excretion is normalized in primary arterial hypertension after perindopril treatment. Biol Trace Elem Res 2006; 114: 127-33.
18. Koren-Michowitz M, Dishy V, Zaidenstein R, et al., The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study. Am J Hypertens 2005; 18: 358-63.
19. Lowe NM, Fekete K, Decsi T, Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr 2009; 89: 2040S-51S.
20. Groff J, Gropper S,. Advanced Nutrition and Human Metabolism, 3rd edn. Belmont, USA: Wadsworth, 1999.
21. Solomons N, Zinc. In: Encyclopedia of Food Sciences and Nutrition, Benjamin Caballero, ed. 2nd edn. Elsevier, 2003: 6277-83.
22. Tubek S,. Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol Trace Elem Res 2007; 117: 39-51.
23. Tubek S,. Increased absorption of zinc from alimentary tract in primary arterial hypertension. Biol Trace Elem Res 2001; 83: 31-8.
24. Oates J, Brown N,. Chapter 33: Antihypertensive agents and the drug therapy of hypertension. In:, Hardman J, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10 edn. Sydney: McGraw-Hill, 2001: 883.
25. Reyes AJ, Olhaberry JV, Leary WP, Lockett CJ, van der Byl K,. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J 1983; 64: 936-41.
26. Trasobares E, Corbaton A, Gonzalez-Estecha M, et al., Effects of angiotensin-converting enzyme inhibitors (ACE i) on zinc metabolism in patients with heart failure. J Trace Elem Med Biol 2007; 21 (Supp. 1): 53-55.